Drug Detail

Information about PF-05212384

Generic Name
IND
PF-05212384
Brand Name (US)
Manufacturer
Pfizer
Drug Type
Delivery
Intravenous
Approval Status
Indications
Overall Strategy
Oncogenic Signal Path Based
Strategy
Block KIT Signal Path
Drug Category
PI3K/mTOR inhibitor


Links


Trials of this drug


Trial results


Search for this drug/combination in:

ClinicalTrials.gov

ASCO

Pubmed